Senti Biosciences Holdings, Inc. ·
SNTI 8-K 2026-09-24
Senti Biosciences Holdings, Inc. (SNTI) 8-K dated 2026-09-24 — accession 0001628280-26-063369.
Senti Biosciences Holdings, Inc. (SNTI) is a biotechnology company listed on NASDAQ.
Senti Biosciences Holdings, Inc. filed a 8-K on 2026-09-24. Accession 0001628280-26-063369.
This 8-K covers: Director/officer change (Item 5.02). SEC EDGAR holds the official filing and its exhibits.
Latest reported SNTI revenue for 2025-12-31 was $22.0K. Net income was -$61.4M. SNTI currently screens at market cap $29.6M.
Not investment advice. The SNTI SEC hub lists recent forms. The stock page is the research view.